Video Experimental Relacionado
Updated: May 13, 2026

11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Una mutación de un solo punto en el oncogén v-ets afecta tanto a la diferenciación celular eritroide como a la
1Differentiation Program, European Molecular Biology Laboratory, Heidelberg, Federal Republic of Germany.
Cell
|December 23, 1988
Resumen
El virus de la leucemia aviar E26
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- Virología Virología.
Sus antecedentes:
- El virus de la leucemia aviar E26 contiene oncogenes v-myb y ets, capaces de transformar eritroblastos y mieloblastos.
- Investigaciones anteriores indicaron la suficiencia de v-myb para la transformación de células mieloides, pero dejaron sin aclarar el papel de v-ets.
- Comprender las funciones específicas de v-myb y v-ets en la transformación de células hematopoyéticas es crucial para la investigación de la leucemia.
Objetivo del estudio:
- Para aclarar la función específica del gen v-ets en la transformación de las células hematopoyéticas por el virus de la leucemia aviar E26.
- Para investigar los cambios fenotípicos en las células mieloides transformadas por un mutante sensible a la temperatura de E26 con una mutación v-ets.
- Explorar la participación potencial de los V-ET en el compromiso del linaje celular hematopoyético.
Principales métodos:
- Aislamiento y caracterización de un mutante sensible a la temperatura (ts1.1) de E26 con una mutación en el gen v-ets.
- Ensayos de transformación utilizando el mutante ts1.1 en células eritroides y mieloides.
- Análisis fenotípico de células transformadas, incluidos los macrófagos maduros, para evaluar el estado de diferenciación.
Principales resultados:
- El mutante ts1.1 demostró una transformación sensible a la temperatura de las células eritroides.
- Las células mieloides transformadas por ts1.1 exhibieron un fenotipo alterado, parecido a los promyelocitos.
- La infección de los macrófagos maduros con ts1.1 dio lugar a su transformación en células similares a los promyelocitos.
Conclusiones:
- El dominio v-ets de la proteína p135gag-myb-ets influye tanto en la diferenciación celular eritroide como en la mieloide.
- Los hallazgos sugieren un papel potencial para los genes celulares ets (c-ets) y myb (c-myb) en el compromiso del linaje celular hematopoyético.
- Este estudio pone de relieve el papel crítico de los v-ets en la modulación de las vías de diferenciación de las células hematopoyéticas.
Videos de Conceptos Relacionados
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

